Literature DB >> 26398291

Inflammation and hemostasis in atrial fibrillation and coronary heart disease: The REasons for Geographic And Racial Differences in Stroke study.

Wesley T O'Neal1, Elsayed Z Soliman2, George Howard3, Virginia J Howard4, Monika M Safford5, Mary Cushman6, Neil A Zakai6.   

Abstract

BACKGROUND: Recent studies suggest atrial fibrillation (AF) is an independent risk factor for coronary heart disease (CHD). AIMS: To determine if alterations in hemostasis or inflammation explain the association between AF and CHD.
METHODS: C-reactive protein (CRP), D-dimer, factor VIII, and fibrinogen were measured in incident CHD cases (n = 647) and a stratified cohort random sample (CRS, n = 1104) between 2003 and 2007 from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Using a case-cohort approach, Cox models examined whether inflammation or hemostasis biomarkers explained the association between AF and CHD.
RESULTS: In participants free of CHD at baseline, 12.2% of CHD cases and 7.1% of the CRS had AF. Over a median follow-up of 4.4 years, all biomarkers were associated with an increased risk of CHD in those with and those without AF after adjusting for CHD risk factors. The association of D-dimer with CHD was greater in those with AF (HR 2.52, 95% CI = 1.49, 4.26) than those without AF (HR 1.34, 95% CI = 1.12, 1.61) (p-interaction = 0.02). Similar interactions were not observed for the other biomarkers.
CONCLUSIONS: Our results suggest that alterations in D-dimer, a marker of hemostasis, explain the association between AF and CHD. Potentially, D-dimer is a useful biomarker to assess CHD risk in persons with AF.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Atrial fibrillation; Biological markers; Coronary disease

Mesh:

Substances:

Year:  2015        PMID: 26398291      PMCID: PMC4634936          DOI: 10.1016/j.atherosclerosis.2015.09.009

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  39 in total

1.  ABO blood type and stroke risk: the REasons for Geographic And Racial Differences in Stroke Study.

Authors:  N A Zakai; S E Judd; K Alexander; L A McClure; B M Kissela; G Howard; M Cushman
Journal:  J Thromb Haemost       Date:  2014-04       Impact factor: 5.824

2.  Atrial fibrillation and incident myocardial infarction in the elderly.

Authors:  Wesley T O'Neal; Kunal Sangal; Zhu-Ming Zhang; Elsayed Z Soliman
Journal:  Clin Cardiol       Date:  2014-11-17       Impact factor: 2.882

3.  A multicentric prospective study in usual care: D-dimer and cardiovascular events in patients with atrial fibrillation.

Authors:  Isabelle Mahé; Jean-François Bergmann; Olivier Chassany; Claire Bal dit-Sollier; Guy Simoneau; Ludovic Drouet
Journal:  Thromb Res       Date:  2011-09-13       Impact factor: 3.944

4.  Validating laboratory results in a national observational cohort study without field centers: the Reasons for Geographic and Racial Differences in Stroke cohort.

Authors:  Sarah R Gillett; Rebekah H Boyle; Neil A Zakai; Leslie A McClure; Nancy S Jenny; Mary Cushman
Journal:  Clin Biochem       Date:  2014-08-14       Impact factor: 3.281

5.  High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis.

Authors:  Gregory Y H Lip; Jeetesh V Patel; Elizabeth Hughes; Robert G Hart
Journal:  Stroke       Date:  2007-03-01       Impact factor: 7.914

Review 6.  Biomarkers in atrial fibrillation: a clinical review.

Authors:  Ziad Hijazi; Jonas Oldgren; Agneta Siegbahn; Christopher B Granger; Lars Wallentin
Journal:  Eur Heart J       Date:  2013-02-05       Impact factor: 29.983

7.  Atrial fibrillation and the risk of myocardial infarction.

Authors:  Elsayed Z Soliman; Monika M Safford; Paul Muntner; Yulia Khodneva; Farah Z Dawood; Neil A Zakai; Evan L Thacker; Suzanne Judd; Virginia J Howard; George Howard; David M Herrington; Mary Cushman
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

8.  Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation.

Authors:  Eleni Hatzinikolaou-Kotsakou; Dimitrios Tziakas; Athanasios Hotidis; Dimitrios Stakos; Dimitrios Floros; Nikolaos Papanas; Georgios Chalikias; Efstratios Maltezos; Dimitrios Ioanni Hatseras
Journal:  Am J Cardiol       Date:  2006-01-06       Impact factor: 2.778

9.  Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.

Authors:  Sam Schulman; Ajay K Kakkar; Samuel Z Goldhaber; Sebastian Schellong; Henry Eriksson; Patrick Mismetti; Anita Vedel Christiansen; Jeffrey Friedman; Florence Le Maulf; Nuala Peter; Clive Kearon
Journal:  Circulation       Date:  2013-12-16       Impact factor: 29.690

10.  Association of race and sex with risk of incident acute coronary heart disease events.

Authors:  Monika M Safford; Todd M Brown; Paul M Muntner; Raegan W Durant; Stephen Glasser; Jewell H Halanych; James M Shikany; Ronald J Prineas; Tandaw Samdarshi; Vera A Bittner; Cora E Lewis; Christopher Gamboa; Mary Cushman; Virginia Howard; George Howard
Journal:  JAMA       Date:  2012-11-07       Impact factor: 56.272

View more
  14 in total

1.  Role of diabetes and insulin use in the risk of stroke and acute myocardial infarction in patients with atrial fibrillation: A Medicare analysis.

Authors:  Amgad Mentias; Ghanshyam Shantha; Oluwaseun Adeola; Geoffrey D Barnes; Bharat Narasimhan; Konstantinos C Siontis; Deborah A Levine; Rajan Sah; Michael C Giudici; Mary Vaughan Sarrazin
Journal:  Am Heart J       Date:  2019-05-10       Impact factor: 4.749

Review 2.  Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review.

Authors:  Alexander Weymann; Anton Sabashnikov; Sadeq Ali-Hasan-Al-Saegh; Aron-Frederik Popov; Seyed Jalil Mirhosseini; William L Baker; Mohammadreza Lotfaliani; Tong Liu; Hamidreza Dehghan; Senol Yavuz; Michel Pompeu Barros de Oliveira Sá; Jae-Sik Jang; Mohamed Zeriouh; Lei Meng; Fabrizio D'Ascenzo; Abhishek J Deshmukh; Guiseppe Biondi-Zoccai; Pascal M Dohmen; Hugh Calkins; Integrated Meta-Analysis Of Cardiac Cardiac Surgery And Cardiology-Group Imcsc-Group
Journal:  Med Sci Monit Basic Res       Date:  2017-03-31

3.  D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study.

Authors:  Laura M Raffield; Neil A Zakai; Qing Duan; Cecelia Laurie; Joshua D Smith; Marguerite R Irvin; Margaret F Doyle; Rakhi P Naik; Ci Song; Ani W Manichaikul; Yongmei Liu; Peter Durda; Jerome I Rotter; Nancy S Jenny; Stephen S Rich; James G Wilson; Andrew D Johnson; Adolfo Correa; Yun Li; Deborah A Nickerson; Kenneth Rice; Ethan M Lange; Mary Cushman; Leslie A Lange; Alex P Reiner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-09-14       Impact factor: 8.311

4.  Prevalence, Epidemiological Characteristics, and Pharmacotherapy of Coronary Artery Disease among Patients with Atrial Fibrillation: Data from Jo-Fib Study.

Authors:  Hanna K Al-Makhamreh; Mohammed Q Al-Sabbagh; Ala' E Shaban; Abdelrahman F Obiedat; Ayman J Hammoudeh
Journal:  Medicina (Kaunas)       Date:  2021-06-11       Impact factor: 2.430

Review 5.  Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms.

Authors:  Francesco Violi; Elsayed Z Soliman; Pasquale Pignatelli; Daniele Pastori
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

Review 6.  The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio Mirror.

Authors:  Feliciano Chanana Paquissi
Journal:  J Biomark       Date:  2016-07-03

7.  Usual blood pressure, atrial fibrillation and vascular risk: evidence from 4.3 million adults.

Authors:  Connor A Emdin; Simon G Anderson; Gholamreza Salimi-Khorshidi; Mark Woodward; Stephen MacMahon; Terrence Dwyer; Kazem Rahimi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

8.  D-dimer in the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis.

Authors:  Guangxu Lu; Tong Li; Haoqi Ye; Shujin Liu; Peng Zhang; Wenliang Wang
Journal:  J Orthop Surg Res       Date:  2020-07-16       Impact factor: 2.359

9.  Soluble CD14, Ischemic Stroke, and Coronary Heart Disease Risk in a Prospective Study: The REGARDS Cohort.

Authors:  Nels C Olson; Insu Koh; Alex P Reiner; Suzanne E Judd; Marguerite R Irvin; George Howard; Neil A Zakai; Mary Cushman
Journal:  J Am Heart Assoc       Date:  2020-03-11       Impact factor: 5.501

10.  Intracoronary and peripheral blood levels of TNF-like Cytokine 1A (TL1A) in patients with acute coronary syndrome.

Authors:  Xinjing Chen; Yansong Guo; Li Lai; Shengli Zhang; Zhiliang Li
Journal:  Medicine (Baltimore)       Date:  2020-05-29       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.